Tumor DNA in Blood Reveals Lymphoma Progression

Posted on by admin

Illustration of the lymphatic system. Tumor DNA in Blood Reveals Lymphoma Progression
Using an advanced genetic test, researchers detected diffuse large B-cell lymphoma in blood before it could be seen on CT scans. The technique could improve disease monitoring.
SOURCE: NIH Research Matters – Read entire story here.

Related posts:

  1. CHOP Global Health Center performs first rigorous study of CP outcomes in Africa Cerebral palsy (CP) is the most common cause of childhood disability in the world, affecting between 1 and 2 infants per thousand. But the neurological condition tends to be understudied, especially in developing countries. ...
  2. New biotechnology for high efficiency purification of live human cells One of the reasons pluripotent stem cells are so popular in medical research is that they can be differentiated into any cell type. ...
  3. Auditory deprivation from hearing loss may cause cognitive decline A University of Arizona collaborative study among the Departments of Otolaryngology – Head & Neck Surgery; Speech, Language and Hearing Sciences; and Psychology received approval in early May to begin accepting human subjects in an effort to determine whether older adults suffering from prolonged hearing loss receive a cognitive boost after cochlear implant surgery. ...
  4. KeyGenes can predict future identity of human fetal stem cells A snapshot of gene activity is now all that's necessary to determine what organ or tissue type that a cluster of fetal stem cells will ultimately become. ...
  5. Devices Assess Cancer Drugs in Tumors Devices Assess Cancer Drugs in Tumors Two devices, developed independently, can gauge how tumors respond to various drugs. With further development, they could help determine ideal individual treatments. ...

Related Posts

Precision medicine is ‘personalized, problematic, and promising’

The rapidly emerging field of precision medicine is a “disruptive innovation” that offers the possibility of remarkably fine-tuned remedies to improve patient health while minimizing the risk of harmful side effects, says J. Larry Jameson, MD, PhD, dean of the Perelman School of Medicine and executive vice president of the University of Pennsylvania for the Health System, in this week’s issue of the New England Journal of Medicine. Writing with oncologist Dan L. Longo, MD, a professor of Medicine at Harvard Medical School, in a “Sounding Board” piece, Jameson surveys the terrain of the new field.

Scientists reverse aging in human cell lines and give theory of aging a new lease of life

Can the process of aging be delayed or even reversed? Research led by specially appointed Professor Jun-Ichi Hayashi from the University of Tsukuba in Japan has shown that, in human cell lines at least, it can. They also found that the regulation of two genes involved with the production of glycine, the smallest and simplest amino acid, is partly responsible for some of the characteristics of aging.